Acute lymphocytic leukemia

Acute lymphocytic leukemia is a cancer disease that develops in the bone marrow or blood. They are spongy tissues inside the bones where blood cells form. In this condition, the bone marrow produces large amounts of immature lymphocytes, also known as leukemic cells or lymphoblasts. These immature cells push away the platelets, white blood cells, and red blood cells which in turn causes a lot of complications.

Acute lymphocytic leukemia treatment and diagnosis require prompt attention because it is a life-threatening and serious condition. It can grow quickly and rapidly into a medical emergency if not treated well, unlike persistent leukemias (that progress slowly).

Symptoms

Symptoms depend on the severity of the disease and the involvement of a special type of leukemic cells. However, some of the basic symptoms and signs that indicate this disease are:

Common Symptoms

• Fatigue and weakness: Leukemic cells push away healthy blood cells, leading to energy loss and anemia.
• Frequent infections: A smaller number of white blood cells in the body can decrease the power of the body to resist infections.
• Easy bruising and bleeding: When the number of platelets decreases. It can cause slow blood clotting leading to bleeding and bruising.
• Bone and joint pain: When the leukemic cells gather in the bone marrow. They can cause pain and discomfort in bones and joints. 
• Abdominal discomfort: When the leukemic cells gather in the spleen and liver, they can cause swelling and abdominal pain.
• Headaches and neurological symptoms: Leukemic cells may grow towards the central nervous system in rare cases. It can cause seizures, confusion, or headaches.

Less Common Symptoms

The less common symptoms are:

• Rashes or changes in skin texture
• Swelling on lymph nodes
• Loss of appetite and weight
• Night sweats and fever

When to See a Doctor

You must visit a doctor when you observe symptoms such as frequent infections, constant fatigue, joint and bone pain, easy bleeding or bruising, unexpected weight loss, or abdominal discomfort. These symptoms may lead to acute lymphocytic leukemia, a life-threatening and serious medical condition that needs immediate medical attention.

Regular checkups and screenings are necessary, especially for those having a family history of this condition for its early diagnosis and treatment options. If you need consultation for your symptoms, Fitwell Hub offers expert medical consultations.

Causes and Risk Factors

Causes are not completely understood, but some researchers have discovered different reasons that can cause the development of this condition. 

1- Genetic Factors

Definite chromosomal abnormalities and genetic variations can contribute to the high risk of developing this condition. They include:

• Certain gene mutations, such as those in the TP53 and IKZF1 genes.
• Chromosomal translocations, such as the Philadelphia chromosome.

2- Environmental Factors

Exposure to environmental factors including definite chemicals and radiation can also increase the development risk of this condition. These environmental factors are:

• Usage of definite chemicals including pesticides and benzene.
• Consumption of radiation including from nuclear explosions or medical treatments at higher levels.

3- Age and Gender

This disease is not age-specific but a high percentage of cases occur particularly in children of age under 5. Adults are also at a higher risk of this condition development at the age of above 60. Usually, the development rate of this disease is higher in men than women.

4- Other Risk Factors

Other factors that can increase the risk of developing Acute lymphocytic leukemia include:

• Previous cancer treatment, such as chemotherapy or radiation therapy
• Certain genetic syndromes, such as Down syndrome
• Weakened immune system, such as from HIV/AIDS or certain medications

Understanding the potential risk factors and causes of acute lymphocytic leukemia is crucial for early detection and prevention of this disease.

Diagnosing Acute Lymphocytic Leukemia: Tests and Procedures

Some of the tests and procedures to diagnose ALL are:

Tests

1- Blood Tests

CBC (complete blood count) is the first test to diagnose this disease. This test helps identify abnormalities in various blood cells. If CBC test reports indicate white blood cells abruptly in large numbers, further testing will be recommended.

2- Bone Marrow Aspiration and Biopsy

Bone marrow aspiration and biopsy are used to confirm the diagnosis of this disease. To perform this test, a small portion of bone marrow is taken out as a sample generally from hip bone, then inspected with a microscope to detect the existence of leukemic cells.

3- Imaging Tests

To detect leukemic cells in other body parts including the central nervous system, lymph nodes, or spleen, imaging tests including MRI scans, X-rays, or CT scans can be used.

4- Lumbar Puncture

A lumber puncture called a spinal tap can be performed in rare cases to detect leukemic cells in cerebrospinal fluid (present around the spinal cord and brain).

5- Genetic and Molecular Testing

Genetic and molecular testing can help check chromosomal abnormalities or specific genetic variations. This testing will provide help in treatment decisions and give information on prognosis.

Staging Acute Lymphocytic Leukemia: Classification and Prognosis

Staging plays a key role in the diagnosis process because healthcare providers get information about the extent and severity of the disease. With the help of staging, they can develop a better treatment plan.

Classification

The classification is based on the affected lymphocyte type and the molecular and specific genetic characteristics of the leukemic cells. Common classification of Acute lymphocytic leukemia is:

• Philadelphia chromosome-positive ALL
• T-cell ALL
• Philadelphia chromosome-negative ALL
• B-cell ALL

Prognostic Factors

The outlook or prognosis is different for individuals having acute lymphocytic leukemia depending on various factors including:

• The presence of certain risk factors, such as a weak immune system or previous cancer treatment
• Age at diagnosis
• Response to initial treatment
• Specific genetic and molecular characteristics of the leukemic cells

Treatment

1- Chemotherapy

Acute lymphocytic leukemia treatment is chemotherapy which includes the use of one or more anti-cancer drugs to kill cancerous (leukemic) cells. Chemotherapy is usually given in a series of stages to cause remission (complete removal of leukemic cells) and keep the disease away.

Chemotherapy for acute lymphocytic leukemia treatment consists of different phases, each with its own aims and treatment approach:

2- Induction Therapy

Remission is the primary aim of the first cycle of chemotherapy which is commonly known as induction therapy. It is during this phase that acute lymphocytic leukemia patients typically get a mix of high-dose chemo drugs, usually for some weeks or months.

3- Consolidation Therapy

Once the record shows remission, the next treatment cycle is consolidation therapy whereby the main purpose is to keep the patient healthy and prevent disease return. 

This stage can consist of additional rounds of chemotherapy with the use of immunotherapies or targeted therapies.

4- Maintenance Therapy

Following the first stages of treatment, patients may also go through maintenance therapy that includes low-dose chemotherapy or other prescribed drugs to make their remission last longer and stop the disease from developing again.

5- Central Nervous System (CNS) Prophylaxis

In a few particular cases, patients with acute lymphocytic leukemia may also need additional treatment which prevents the leukemic cells from spreading to the central nervous system (brain and spinal cord).  This can be achieved by the use of intrathecal chemotherapy which involves the direct injection of chemotherapy drugs into the cerebrospinal fluid.

Throughout chemotherapy, individuals with acute lymphocytic leukemia can undergo several side effects such as fatigue, nausea, hair loss, and a higher risk of infections.  To avoid these side effects during treatment, it is necessary to work together with the healthcare professional team to maintain complete well-being and good health.

6- Targeted Therapy

Targeted therapy and immunotherapy are the other two types just like traditional chemotherapy for the treatment of acute lymphocytic leukemia patients. 

The target of these two therapies is leukemic cells with specific molecular or genetic characteristics, usually with fewer side effects than traditional chemotherapy.

7- Immunotherapy

Immunotherapy uses the immune system of the body to fight against leukemic cells to treat acute lymphocytic leukemia patients. Examples of immunotherapies for the treatment of acute lymphocytic leukemia are:

• Chimeric antigen receptor (CAR) T-cell therapy, which involves genetically modifying the patient’s T cells to recognize and attack the leukemic cells
• Bispecific T-cell engager (BiTE) antibodies, such as blinatumomab, help the patient’s T-cells recognize and attack the leukemic cells

These newer treatments have shown promising results in the treatment of acute lymphocytic leukemia, particularly for individuals who have not responded well to traditional chemotherapy or who have relapsed after treatment.

8- Stem Cell Transplantation

In some patients, stem cell transplantation may be recommended as a part of their treatment. This procedure is supposed to be done through the use of the patient’s own body and the destruction of the existing bone marrow and then the replacement with healthy stem cells from a donor or even from the patient’s own body, if possible.

There are two main types of stem cell transplants for acute lymphocytic leukemia treatment:

Autologous Stem Cell Transplant: During the autologous stem cell transplant, the stem cells of the patient are taken and preserved before the high-dose chemotherapy or radiation therapy to kill the bone marrow. Later, the preserved stem cell cells are injected back into the body of the patient. These stem cells will help in rebuilding the bone marrow and restoring the development of healthy blood cells.

Allogeneic Stem Cell Transplant: When a patient receives a stem cell transplant from another person, the transplant is known as allogeneic. Donors can be family members or unrelated persons. A patient’s stem cells mainly originate from the donor and are infused into the body of the patient where the stem cells participate in growing back the bone marrow and recovering the development of healthy blood cells. Stem cell transplantation is usually retained for individuals with high-risk or relapsed acute lymphocytic leukemia, as they may be intensive and provide higher complications of the treatment than others. Nevertheless, for a few people, stem cell transplantation can be the only path toward a cure for the disease or maintaining long-term remission.

Side Effects

Acute lymphocytic leukemia treatment may be intensive and usually has a range of side effects.

• Nausea and vomiting
• Fatigue and weakness
• Hair loss
• Diarrhea
• Bleeding and bruising
• Increased risk of infection
• Nerve damage (neuropathy)
• Mouth sores

To manage these side effects, healthcare providers may recommend a variety of supportive care measures, such as:

• Nutritional support to maintain a healthy weight and prevent malnutrition
• Growth factors to stimulate the production of healthy blood cells
• Antiemetic medications to control nausea and vomiting
• Pain medications to manage discomfort
• Antibiotics and antifungal medications to prevent and treat infections
• Nutritional support to maintain a healthy weight and prevent malnutrition

Acute Lymphocytic Leukemia in Adults

Adult acute lymphocytic leukemia is extensively known to be one of the greatest challenges to be managed because the disease is usually more aggressive and more difficult to treat than children. 

An increased risk of relapse and more unfavorable treatment outcomes is the usual scenario for adult acute lymphocytic leukemia patients. Moreover, these adult cases are likely to be associated with some specific genetic or molecular traits that make the leukemia more repellent to treatment.

The elderly may also be at more risk of these complications due to physiological and pathological changes associated with aging, particularly the immune system and other organ and biological mechanisms. 

Acute Lymphocytic Leukemia in Children

Acute lymphocytic leukemia is the main type of cancer in children and is responsible for nearly one-fourth of all childhood cancers. The key difference in treating pediatric acute lymphocytic leukemia is the intake of highly intensive chemotherapy medicines. In comparison to adults, children show a better ability to cope with the higher dosage of drugs during chemotherapy, which in turn allows for a more aggressive treatment.

Moreover, availing the central nervous system (CNS) prophylaxis is very important as pediatric acute lymphocytic leukemia is more prone to spread to the spinal cord and brain. Adding to the childhood treatment of acute lymphocytic leukemia, a potential problem is the long-range effects of the disease and its treatment. 

Pediatric acute lymphocytic leukemia can face various late effects, including development and growth issues, a higher risk of secondary cancers, and cognitive impairments. Supportive care and careful monitoring are necessary to treat these long-term outcomes and guarantee a good quality of life for acute lymphocytic leukemia patients.

Frequently Ask Questions(FAQ’s)